Doreen Ramogola‐masire - Gynecology

Author Information

Doreen Ramogola-Masire is affiliated with the Department of Obstetrics and Gynecology and the Office of Research and Graduate Studies at the University of Botswana, located at the Corner of Notwane and Mabuto Road, Gaborone, Botswana.

Research Contributions

Doreen Ramogola-Masire has made significant contributions to the field of gynecology, particularly focusing on human papillomavirus (HPV) prevalence, sexually transmitted infections (STIs), and cervical cancer. Her recent work includes studies on HPV prevalence among young adult women living with and without HIV in Botswana, diagnosis and treatment of Chlamydia trachomatis and Neisseria gonorrhoeae in pregnant women, and genetic diversity in HPV among women with cervical cancer. She has also investigated the persistence and clearance of high-risk HPV among women living with HIV, experiences and preferences with STI care, and the impact of the COVID-19 pandemic on gynecologic cancer patient appointments in Botswana.

Aliases

Doreen Ramogola-Masire is also known by several aliases including D Ramogola-masire, D. Ramogola-masire, and Doreen Ramogola-Masire.

Publication and Citation Metrics

Metric	Value
Citation Count	1387
h-index	20
Paper Count	110

Publications:

HPV prevalence among young adult women living with and without HIV in Botswana for future HPV vaccine impact monitoring

DOI: 10.1186/s12879-022-07130-x

Year: 2022

Evaluating the diagnosis and treatment of Chlamydia trachomatis and Neisseria gonorrhoeae in pregnant women to prevent adverse neonatal consequences in Gaborone, Botswana: protocol for the Maduo study

DOI: 10.1186/s12879-022-07093-z

Year: 2022

Human papillomavirus prevalence in male and female university students in Gaborone, Botswana.

DOI: 10.1017/S0950268822000619

Year: 2022

Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya

DOI: 10.1186/s12879-022-07081-3

Year: 2022

Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana

DOI: 10.1186/s12905-022-01680-7

Year: 2022

Persistence and clearance of high‐risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study

DOI: 10.1111/1471-0528.16758

Year: 2021

Hierarchy of qualities in global health partnerships: a path towards equity and sustainability

DOI: 10.1136/bmjgh-2021-007132

Year: 2021

An analysis of tumor microbial diversity and composition between women with cervical cancer in Botswana and the United States

DOI: 10.1016/s0090-8258(21)00806-4

Year: 2021

Experiences and preferences with sexually transmitted infection care and partner notification in Gaborone, Botswana

DOI: 10.1177/09564624211033231

Year: 2021

Gynecologic Cancer: New and Follow-Up Patient Appointments in Botswana During the COVID-19 Pandemic

DOI: 10.1200/GO.20.00590

Year: 2021

How Can Women with Sickle Cell Disease Manage Their Health?

Is Sterilization a Good Option?

What are the Key Nutrients for Women's Health?

How does incorrect coding affect billing?

What is Statistical Analysis in Gynecology?

How Can Flexibility Be Improved?

Are There Specific Supplements That Can Aid Digestion?

How Does Cross Reactivity Affect Diagnostic Tests?

How is Chlamydia Diagnosed?

What Should Gynecologists Look for When Choosing a Cloud-Based EHR System?

Partnered Content Networks

Relevant Topics